Abstract
The hydrogel template strategy was previously developed to fabricate homogeneous polymeric microparticles. Here, we demonstrate the versatility of the hydrogel template strategy for the development of nanowafer-based ocular drug delivery systems. We describe the fabrication of dexamethasone-loaded nanowafers using polyvinyl alcohol and the instillation of a nanowafer on a mouse eye. The nanowafer, a small circular disk, is placed on the ocular surface, and it releases a drug as it slowly dissolves over time, thus increasing ocular bioavailability and enhancing efficiency to treat eye injuries.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131–1135
Novack GD (2009) Ophthalmic drug delivery: development and regulatory considerations. Clin Pharmacol Ther 85:539–543
Kim YC, Chiang B, Wu X et al (2014) Ocular delivery of macromolecules. J Control Release 190:172–181
Gaudana R, Ananthula HK, Parenky A et al (2010) Ocular drug delivery. Am Assoc Pharm Sci J 12:348–360
Ranta VP, Urtti A (2006) Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling. Adv Drug Deliv Rev 58:1164–1181
Mannermaa E, Vellonen KS, Urtti A (2006) Drug transport in corneal epithelium and blood_retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–1163
Jarvinen K, Jarvinen T, Urtti A (1995) Ocular absorption following topical delivery. Adv Drug Deliv Rev 16:3–19
Salminen L (1990) Review: systemic absorption of topically applied ocular drugs in humans. J Ocul Pharmacol 6:243–249
Diebold Y, Calonge M (2010) Applications of nanoparticles in ophthalmology. Prog Retina Eye Res 29:596–609
Gershkovich P, Wasan KM, Barta CA (2008) A review of the application of lipid-based systems in systemic, dermal, transdermal, and ocular drug delivery. Crit Rev Ther Drug 25:545–584
Choy YB, Park JH, McCarey BE et al (2008) Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest Ophthalmol Vis Sci 49:4808–4815
Chang E, McClellan AJ, Farley WJ et al (2011) Biodegradable PLGA-based drug delivery systems for modulating ocular surface disease under experimental murine dry eye. J Clin Exp Ophthalmol 2:191. doi:10.4172/2155-9570.1000191
Aksungur P, Demirbilek M, Denkbas EB et al (2011) Development and characterization of cyclosporine a loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release 151:286–294
Shah M, Edman MC, Janga SR et al (2013) A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren's syndrome. J Control Release 171:269–279
Gulsen D, Chauhan A (2004) Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci 45:2342–2347
Carvalho IM, Marques CS, Oliveira RS et al (2015) Sustained drug release by contact lenses for glaucoma treatment–a review. J Control Release 202:76–82
Garhwal R, Shady SF, Ellis EJ et al (2012) Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials. Invest Ophthalmol Vis Sci 53:1341–1352
Singh K, Nair AB, Kumar A et al (2011) Novel approaches in formulation and drug delivery using contact lenses. J Basic Clin Pharm 2:87–101
Acharya G, Shin CS, McDermott M et al (2010) The hydrogel template method for fabrication of homogeneous nano/micro particles. J Control Release 141:314–319
Acharya G, Shin CS, Vedantham K et al (2010) A study of drug release from homogeneous PLGA microstructures. J Control Release 146:201–206
Acharya G, McDermott M, Shin SJ et al (2011) Hydrogel templates for the fabrication of homogeneous polymer microparticles. Methods Mol Biol 726:179–185
Coursey TG, Henriksson JT, Marcano DC et al (2015) Dexamethasone nanowafer as an effective therapy for dry eye disease. J Control Release 213:168–174
Yuan X, Marcano DC, Shin CS et al (2015) Ocular drug delivery nanowafer with enhanced therapeutic efficacy. ACS Nano 9:1749–1758
Ludwig A (2005) The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 57:1595–1639
Moshirfar M, Pierson K, Hanamaikai K et al (2014) Artificial tears potpourri: a literature review. Clin Ophthalmol 8:1419–1433
Nagelhout TJ, Gamache DA, Roberts L et al (2005) Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye. J Ocul Pharmacol Ther 21:139–148
Patane MA, Cohen A, From S et al (2011) Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial. Clin. Ophthalmol. 5:633–643
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Shin, C.S., Marcano, D.C., Park, K., Acharya, G. (2017). Application of Hydrogel Template Strategy in Ocular Drug Delivery. In: Petrosko, S., Day, E. (eds) Biomedical Nanotechnology. Methods in Molecular Biology, vol 1570. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6840-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6840-4_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6838-1
Online ISBN: 978-1-4939-6840-4
eBook Packages: Springer Protocols